Medtronic gets FDA approval for ‘next gen’ CGM development
At the end of 2011 Medtronic announced the Food and Drug Administration (FDA) approval of iPro2, a next generation Professional continuous glucose monitoring (CGM) system
At the end of 2011 Medtronic announced the Food and Drug Administration (FDA) approval of iPro2, a next generation Professional continuous glucose monitoring (CGM) system